Incorporated in 2005, AGI Infra Ltd is in the business of Real Estate and Construction Services
The company possesses a narrow moat based on its regional scale and execution track record in the Punjab real estate market, corroborated by stable net margins above 14% and high ROCE. While real estate is generally a commodity business, their adoption of MIVAN technology provides a cost and speed advantage over local fragmented competitors.
Earnings are primarily reinvested into land acquisition and new project development, which has successfully driven a 30% EPS CAGR. The company maintains a conservative debt-to-equity ratio while paying a consistent but modest 10% dividend.
The investment collapsed as the 325 Crore related party transaction with the promoter's private construction arm proved to be a conduit for siphoning capital rather than a legitimate business expense. As the Punjab real estate cycle turned, the company's manual inventory valuation processes were revealed to be masking significant impairments, while the 73% surge in finance charges triggered a liquidity crunch. The lack of institutional oversight allowed the promoter family to prioritize their private interests over minority shareholders, leading to a permanent re-rating of the stock as a 'governance-trap' rather than a growth story.
RichFakir rates AGI Infra Ltd's business quality as decent — 67/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, AGI Infra Ltd is trading about 41% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on AGI Infra Ltd is: Watch — wait for price. A decent business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of AGI Infra Ltd's fair value is about ₹171 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →